LPL Financial
BIIB icon

LPL Financial’s Biogen BIIB Stock Holding History

LPL Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,000
Closed -$388K – 5297
2024
Q3 		$388K Hold
2,000
– – ﹤0.01% 4224
2024
Q2 		$464K Buy
+2,000
New +$435K ﹤0.01% 3937

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LPL Financial's BIIB Position: Q1 2026 in Review

LPL Financial reduced its Biogen (BIIB) stake by 8.7% in Q1 2026, selling an estimated $1.44M and leaving 81,720 shares worth $15M. The position accounts for ﹤0.01% of the portfolio, ranked #1684.

LPL Financial first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.2M in Q4 2017. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • LPL Financial held 81,720 shares of Biogen worth $15M as of Q1 2026.
  • LPL Financial sold 7,817 Biogen shares in Q1 2026, an estimated $1.44M.
  • Biogen made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #1684 holding.
  • LPL Financial first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • LPL Financial's Biogen position peaked at $16.2M in Q4 2017.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.